Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Lactobacillus Live Capsules to Prevent Recurrence of Bacterial Vaginosis
CTR20170311Phase 2Suspended
- Sponsor
- Osaweike Biopharma
- Start
- Jul 2017
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of vaginal live lactobacillus in bacterial vaginosis (BV), sponsored by Osaweike Biopharma. Started Jul 2017; status: suspended.
02
Drugs
vaginal live lactobacillus
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on CTR20170311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170311.